The absence of B2M, HLA-I and CD58 in 60% of DLBCL patients signifies the role of lymphomagenesis in protecting cell-mediated lysis of CTL and NK cell [70]. This evidence concerns the gene CD58 and diffuse large B-cell lymphoma.